The nurse at the hematology office is reinforcing education to a patient with thalassemia. Which description of thalassemia should the nurse use? Do you know the answer? Let’s find out!

A. “Thalassemia is a set of genetic disorders characterized by mutations in the hemoglobin gene, impairing the function and number of red blood cells.”

B. “Thalassemia is a set of genetic disorders characterized by mutations in the bone marrow, impairing the function and number of stem cells.”

C. “Thalassemia is a set of genetic disorders characterized by mutations in the liver, impairing the production of clotting factors.”

D. “Thalassemia is a set of genetic disorders characterized by mutations in the white blood cell gene, impairing the production of leukocytes.

Scroll down for the correct answer!

The correct answer to today’s NCLEX-PN® Question is…

A. “Thalassemia is a set of genetic disorders characterized by mutations in the hemoglobin gene, impairing the function and number of red blood cells.

Main Takeaway

Thalassemia is a set of genetic disorders characterized by mutations in the hemoglobin gene, which impairs the function and number of red blood cells, causing anemia. There are two primary types of thalassemia: alpha thalassemia and beta-thalassemia, both of which can have minor or major versions. Thalassemia is not a set of genetic disorders characterized by mutations in the bone marrow, liver, or white blood cell gene.

Educational graphic explaining thalassemia. It shows a genetic disorder affecting hemoglobin, leading to impaired red blood cell function and number, and resulting in anemia. The graphic notes two primary types: alpha thalassemia (minor or major) and beta thalassemia (minor or major), illustrated with icons of chromosomes, hemoglobin, and red blood cells.

Incorrect Answer Explanations

B. “Thalassemia is a set of genetic disorders characterized by mutations in the bone marrow, impairing the function and number of stem cells.”

Rationale: Thalassemia is not a set of genetic disorders characterized by mutations in the bone marrow, impairing the function and number of stem cells.

C. “Thalassemia is a set of genetic disorders characterized by mutations in the liver, impairing the production of clotting factors.”

Rationale: Thalassemia does not refer to a set of genetic disorders characterized by mutations in the liver, impairing the production of clotting factors.

D. “Thalassemia is a set of genetic disorders characterized by mutations in the white blood cell gene, impairing the production of leukocytes.”

Rationale: Thalassemia is not a set of genetic disorders characterized by mutations in the white blood cell gene, impairing the production of leukocytes.

Want to learn more about this topic?

Watch the Osmosis video: Thalassemia: Nursing

Try Osmosis from Elsevier today! Access your free trial and find out why millions of current and future clinicians and caregivers love learning with us.

, , , ,

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *